# Cyproterone

## Androcur 50mg

| 藥物代碼           | OAND                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | 為抗雄性素製劑(B012554100)Men: Reduction of drive in sexual deviations. Antiandrogen treatment in inoperable carcinoma of the prostate. Women: Severe signs of androgenization, eg very severe hirsutism, androgen-dependent severe loss of scalp hair eventually resulting in baldness (severe androgenetic alopecia), often attended by severe forms of acne &/or seborrhoea.             |
| 副作用             | Decreased libido, erectile dysfunction, inhibition of ovulation, reversible inhibition of spermatogenesis, weight increase/decrease, mood depression, restlessness, breast tenderness, gynecomastia, fatigue, hot flushes, sweating.                                                                                                                                                        |
| 禁忌               | Hypersensitivity to cyproterone or any component of the formulation; liver disease or hepatic dysfunction; Dubin-Johnson syndrome; Rotor syndrome; previous or existing liver tumors (if not due to metastases from prostate cancer); presence or history of meningioma; wasting diseases (except inoperable prostate cancer); severe chronic depression; existing thromboembolic processes |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                        |
| 用法用量           | Prostatic carcinoma:  Initial: 300 mg/day in 2-3 divided doses, pc.  Maintenance: 200-300 mg/day. Sexual disorders: Initially, 50-100 mg bid; may be reduced to 25 mg bid. Severe hirsutism: 100 mg/day x 10 days from day 5 alone or with estradiol mcg/day x 17 days/month. Precocious puberty: 50-150 mg/m2/day (25-50 mg bid to 50 mg tid).                                             |
| 肝功能異常         | 需 調 整 劑 量  肝功能異常者為禁忌                                                                                                                                                                                                                                                                                                                                                          |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                    |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                         |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                         |
| 哺乳期用藥建議     | Unknown 尚未建立                                                                                                                                                                                                                                                                                                                                                                            |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                         |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                         |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                         |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                         |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                         |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                         |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                         |

